| Datum | Källa | Rubrik | Typ | Alternativ |
|---|---|---|---|---|
| 2023-09-08 | Elicera Therapeutics | Elicera Therapeutics får besked om beviljande av kinesiskt patent som skyddar iTANK-plattformen | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-09-08 | Elicera Therapeutics | Elicera Therapeutics receives Notice of Allowance for Chinease patent protecting the iTANK platform | Pressreleaser | Ladda ner | Visa Stäng |
|
Pressreleaser |
Elicera Therapeutics receives Notice of Allowance for Chinease patent protecting the iTANK platform
Once granted, the patent can be kept in force until 2036. ”iTANK is one of our key assets and together with the recently approved European patent we now have strong protection for the technology. China is one of the most important markets in the CAR T-cell field so this is very significant for us,” says Jamal El-Mosleh , CEO of Elicera Therapeutics. |
||||
| 2023-08-30 | Penser Future | Penser Future: I väntan på studiestart - Elicera Therapeutics | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-08-29 | Elicera Therapeutics | Elicera Therapeutics AB (publ) Delårsrapport 1 januari - 30 juni 2023 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-08-29 | Elicera Therapeutics | Elicera Therapeutics AB (publ) Interim Report 1 January - 30 June 2023 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-08-15 | Elicera Therapeutics | Elicera Therapeutics: BioStock: Elicera's potential in cancer therapy published in Nature Communications | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-08-15 | Elicera Therapeutics | Elicera Therapeutics: BioStock: Eliceras potential inom cancerterapi publicerad i Nature Communications | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-08-10 | Elicera Therapeutics | Elicera Therapeutics publicerar en vetenskaplig artikel i Nature Communications om CAR T-konstruktionen i ELC-401 | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-08-10 | Elicera Therapeutics | Elicera Therapeutics publishes a scientific article in Nature Communications about the CAR T construct in the ELC-401 program | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-07-13 | Elicera Therapeutics | BioStock: Elicera Therapeutics receives important EU patent | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-07-13 | Elicera Therapeutics | BioStock: Elicera Therapeutics säkrar viktigt EU-patent | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-07-11 | Elicera Therapeutics | Elicera Therapeutics receives Notice of Allowance for European patent protecting the iTANK[TM] platform | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-07-11 | Elicera Therapeutics | Elicera Therapeutics får besked om beviljande av europeiskt patent som skyddar iTANK[TM]-plattformen | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-06-30 | Elicera Therapeutics | Elicera Therapeutics: BioStock: Elicera gives an update in Cancer Immunotherapy Month | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-06-30 | Elicera Therapeutics | Elicera Therapeutics: BioStock: Elicera uppdaterar i samband med Cancer Immunotherapy Month | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-05-31 | Elicera Therapeutics | BioStock Life Science Spring Summit with Elicera Therapeutics | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-05-31 | Elicera Therapeutics | BioStock Life Science Spring Summit med Elicera Therapeutics | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-05-24 | Elicera Therapeutics | Elicera Therapeutics: BioStock: Well-financed Elicera prepared for clinic and business development | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-05-24 | Elicera Therapeutics | Elicera Therapeutics: BioStock: Välfinansierat Elicera beredda för klinik och affärsutveckling | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-05-17 | Penser Future | Penser Future: Väl rustad för pågående och planerade kliniska studier - Elicera Therapeutics | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-05-16 | Elicera Therapeutics | Kommuniké från årsstämma i Elicera Therapeutics AB (publ) den 16 maj 2023 | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-05-16 | Elicera Therapeutics | Elicera Therapeutics AB (publ) Delårsrapport 1 januari - 31 mars 2023 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-05-16 | Elicera Therapeutics | Elicera Therapeutics AB (publ) Interim Report 1 January - 31 March 2023 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-05-15 | Penser Future | Penser Future: Intervju med Elicera Therapeutics - Erik Penser Bank - 15 maj 2023 | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-05-10 | Elicera Therapeutics | Elicera Therapeutics: BioStock: Janssens CAR T-avtal ger stöd till Eliceras vision | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-05-10 | Elicera Therapeutics | Elicera Therapeutics: BioStock: Janssen CAR T deal supports Elicera's vision | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-05-09 | Elicera Therapeutics | BioStock Studio: Elicera Therapeutics om Läkemedelsverkets villkorade godkännande | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-05-03 | Penser Future | Penser Future: Miljardaffär inom NHL-området - Elicera Therapeutics | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-05-02 | Penser Future | Penser Future: Villkorat godkännande från Läkemedelsverket - Elicera Therapeutics | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-05-02 | Carlsquare | Carlsquare: Mrkt BUZZ Elicera Therapeutics: Ett steg närmare klinik för CAR T-projekt | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-04-28 | Elicera Therapeutics | Elicera Therapeutics erhåller villkorat godkännande från Läkemedelsverket för ansökan om klinisk prövning (CARMA-studien) med CAR T-cellsterapin ELC-301 | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-04-28 | Elicera Therapeutics | Elicera Therapeutics receives conditional approval from the Medical Products Agency on its CAR T-cell Clinical Trial Application to test ELC-301 (CARMA-study) | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-04-17 | Elicera Therapeutics | Elicera Therapeutics publicerar årsredovisningen för 2022 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-04-17 | Elicera Therapeutics | Elicera Therapeutics publishes the annual report for 2022 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-04-11 | Elicera Therapeutics | Kallelse till årsstämma i Elicera Therapeutics AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-03-30 | Elicera Therapeutics | Elicera Therapeutics: BioStock: Elicera om CAR T-cellers potential utanför blodcancer | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-03-30 | Elicera Therapeutics | Elicera Therapeutics: BioStock: Elicera on CAR T-cells' potential beyond blood cancer | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-03-28 | Penser Future | Penser Future: Analytikerpresentation av Elicera Therapeutics - Erik Penser Bank - 28 mars 2023 | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-03-06 | Elicera Therapeutics | Erik Penser Bank inleder bevakning på Elicera Therapeutics | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-03-06 | Elicera Therapeutics | Erik Penser Bank initiates coverage on Elicera Therapeutics | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-03-06 | Penser Future | Penser Future: Immunonkologi på svenskt sätt - Elicera Therapeutics | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-03-01 | Elicera Therapeutics | Elicera Therapeutics hires Erik Penser Bank as market maker | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-03-01 | Elicera Therapeutics | Elicera Therapeutics ingår avtal om likviditetsgaranti med Erik Penser Bank | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-02-23 | Elicera Therapeutics | Elicera Therapeutics: BioStock: Advancements for Elicera in 2022 open for intensive clinical year | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-02-23 | Elicera Therapeutics | Elicera Therapeutics: BioStock: Avancemang i Eliceras 2022 öppnar för intensivt kliniskt år | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-02-17 | Elicera Therapeutics | Elicera Therapeutics AB (publ) Year-end Report 1 January - 31 December 2022 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-02-17 | Elicera Therapeutics | Elicera Therapeutics AB (publ) Bokslutskommuniké 1 januari - 31 december 2022 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-02-08 | Elicera Therapeutics | Elicera Therapeutics: BioStock: Elicera on AstraZeneca's acquisition of Neogene Therapeutics | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-02-08 | Elicera Therapeutics | Elicera Therapeutics: BioStock: Elicera om AstraZenecas förvärv av Neogene Therapeutics | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-02-07 | Elicera Therapeutics | Elicera Therapeutics recruits LifeSci Consulting as transaction advisor to assist the company in evaluating strategic partnering initiatives | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-02-07 | Elicera Therapeutics | Elicera Therapeutics rekryterar LifeSci Consulting som transaktionsrådgivare för att bistå företaget med att utvärdera strategiska partnerskapsinitiativ | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-01-26 | Elicera Therapeutics | Elicera Therapeutics lämnar in ansökan om klinisk prövning för att utvärdera sin CAR T-cellsterapi vid behandling av B-cellslymfom | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-01-26 | Elicera Therapeutics | Elicera Therapeutics submits Clinical Trial Application to evaluate its CAR T-cell therapy in B-cell lymphoma | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-01-23 | Elicera Therapeutics | Elicera Therapeutics continues phase I/IIa study with oncolytic virus as planned, following safety review in cohort 3 | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-01-23 | Elicera Therapeutics | Elicera Therapeutics fortsätter fas I/IIa-studien med onkolytiskt virus som planerat, efter säkerhetskommitténs bedömning i kohort 3 | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-01-17 | Elicera Therapeutics | Valberedningen föreslår omval av styrelsen i Elicera Therapeutics | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2022-12-15 | Elicera Therapeutics | Elicera Therapeutics: BioStock: Elicera on the positive clinical effect in cancer trial | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-12-15 | Elicera Therapeutics | Elicera Therapeutics: BioStock: Elicera om den positiva kliniska effekten i cancerstudien | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-12-07 | Elicera Therapeutics | Elicera Therapeutics redovisar ytterligare signaler på klinisk aktivitet från patienter med neuroendokrina tumörer i studien med ELC-100 vid Oncolytic Virotherapy Summit i Boston | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2022-12-07 | Elicera Therapeutics | Elicera Therapeutics reports additional signals of clinical activity in patients treated for neuroendocrine tumors in the ELC-100 study at the Oncolytic Virotherapy Summit in Boston | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2022-11-23 | Carlsquare | Carlsquare: Analysuppdatering, Elicera Therapeutics: Med nästa kliniska studie i siktet | Analyser | Ladda ner | Visa Stäng |
|
|
||||
| 2022-11-22 | Elicera Therapeutics | Elicera Therapeutics: BioStock: Eliceras vd: "iTANK-partnering intensifieras" | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-11-22 | Elicera Therapeutics | Elicera Therapeutics: BioStock: Elicera's CEO: "iTANK partnering is intensifying" | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-11-18 | Elicera Therapeutics | Elicera Therapeutics AB (publ) Delårsrapport 1 januari - 30 september 2022 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2022-11-18 | Elicera Therapeutics | Elicera Therapeutics AB (publ) Interim Report 1 January - 30 September 2022 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2022-11-16 | Elicera Therapeutics | Elicera Therapeutics' co-founders receive additional grants totalling 7,65 MSEK from the Swedish Cancer Society to support CAR T research | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2022-11-16 | Elicera Therapeutics | Elicera Therapeutics medgrundare får ytterligare bidrag på totalt 7,65 MSEK från Cancerfonden för att stödja CAR T-forskning | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2022-11-03 | Elicera Therapeutics | Elicera Therapeutics utser valberedning | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2022-11-03 | Elicera Therapeutics | Nomination Committee for Elicera Therapeutics appointed | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2022-10-19 | Elicera Therapeutics | BioStock: Elicera Therapeutics enters first international collaboration involving iTANK | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-10-19 | Elicera Therapeutics | BioStock: Elicera Therapeutics tecknar första internationella samarbetsavtalet kring iTANK | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-10-18 | Elicera Therapeutics | Elicera Therapeutics enters first international collaboration involving the iTANK platform with a Spanish research institution | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2022-10-18 | Elicera Therapeutics | Elicera Therapeutics tecknar det första internationella samarbetsavtalet kring iTANK-plattformen med ett spanskt forskningsinstitut | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2022-10-12 | Elicera Therapeutics | Elicera Therapeutics: PhD thesis describing the iTANK-platform awarded best of the year 2021 in Sweden in the field of gene and cell therapy | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2022-10-12 | Elicera Therapeutics | Elicera Therapeutics: Doktorsavhandling som beskriver iTANK-plattformen utsedd till årets bästa i Sverige inom forskningsfältet gen och cellterapi för 2021 | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2022-10-03 | Elicera Therapeutics | Elicera Therapeutics byter Certified Adviser till Erik Penser Bank AB | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2022-09-27 | Elicera Therapeutics | BioStock Investor Meeting: Interview with Elicera Therapeutics | Pressreleaser | Visa Stäng |
|
|
||||
| 2022-09-27 | Elicera Therapeutics | BioStock Investor Meeting: Intervju med Elicera Therapeutics | Pressreleaser | Visa Stäng |
|
|
||||
Kommande händelser
